Catalina Capital Group, LLC Adagene Inc. Transaction History
Catalina Capital Group, LLC
- $299 Billion
- Q3 2024
A detailed history of Catalina Capital Group, LLC transactions in Adagene Inc. stock. As of the latest transaction made, Catalina Capital Group, LLC holds 12,737 shares of ADAG stock, worth $24,964. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,737
Previous 16,752
23.97%
Holding current value
$24,964
Previous $51.3 Million
44.86%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ADAG
# of Institutions
13Shares Held
9.87MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$7.81 Million46.44% of portfolio
-
Fil LTD Hamilton, D03.6MShares$7.06 Million0.01% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$2.63 Million0.11% of portfolio
-
General Atlantic LLC New York, NY264KShares$517,4400.02% of portfolio
-
Exome Asset Management LLC New York, NY263KShares$514,7450.4% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $85.1M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...